(Q40031893)

16 September 2017

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations (English)

1 reference

16 September 2017

1 reference

1

1 reference

16 September 2017

3

1 reference

16 September 2017

5

1 reference

16 September 2017

6

1 reference

16 September 2017

7

1 reference

16 September 2017

Figueiredo J

2

0 references

author name string

Ribeiro AS

series ordinal

4

1 reference

16 September 2017

1 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

214

1 reference

16 September 2017

320-327

1 reference

16 September 2017

3

1 reference

Mutations of the BRAF gene in human cancer

16 September 2017

1 reference

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

21 January 2018

1 reference

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

21 January 2018

1 reference

Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

21 January 2018

1 reference

Differential regulation and properties of MAPKs

21 January 2018

1 reference

Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells

21 January 2018

1 reference

Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited

21 January 2018

1 reference

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

21 January 2018

1 reference

B-RAF is a therapeutic target in melanoma

21 January 2018

1 reference

Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.

21 January 2018

1 reference

BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells

21 January 2018

1 reference

BRAF is a therapeutic target in aggressive thyroid carcinoma.

21 January 2018

1 reference

Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo

21 January 2018

1 reference

Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines.

21 January 2018

1 reference

Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers.

21 January 2018

1 reference

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

Hyperactive Ras in developmental disorders and cancer

21 January 2018

1 reference

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis

21 January 2018

1 reference

RAF/RAS oncogenes and mismatch-repair status

21 January 2018

1 reference

Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling

21 January 2018

1 reference

BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency

21 January 2018

1 reference

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2295

1 reference

16 September 2017

1 reference

PubMed ID

18098337